InsiderTrades.com logo

EVOK Insider Trading

Insider Ownership Percentage: 2.29%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $96,029.99

Evoke Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Evoke Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Evoke Pharma Share Price & Price History

Current Price: $10.94
Price Change: ▲ Price Increase of +0.01 (0.09%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for EVOK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Evoke Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/6/2025Roger M KleinMajor ShareholderSell9,000$10.65$95,850.0029,000View SEC Filing Icon  
1/28/2025Nantahala Capital Management,Major ShareholderSell41$4.39$179.99148,153View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Evoke Pharma (NASDAQ:EVOK)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at EVOK by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Evoke Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/31/2025National Wealth Management Group LLC80,130$0.40M0.1%N/A5.140%Search for SEC Filing on Google Icon
2/14/2025Nantahala Capital Management LLC148,194$0.66M0.0%+163.5%9.946%Search for SEC Filing on Google Icon
11/14/2024Corsair Capital Management L.P.11,667$56K0.0%N/A1.425%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.175,559$0.23M0.0%+9.2%0.541%Search for SEC Filing on Google Icon
11/2/2021Raymond James Financial Services Advisors Inc.108,545$0.14M0.0%-8.9%0.335%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Evoke Pharma logo
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
Read More on Evoke Pharma

Today's Range

Now: $10.94
Low: $10.91
High: $10.94

50 Day Range

MA: $7.52
Low: $4.46
High: $10.94

52 Week Range

Now: $10.94
Low: $1.94
High: $10.94

Volume

9,564 shs

Average Volume

36,538 shs

Market Capitalization

$18.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Evoke Pharma?

Evoke Pharma's top insider investors include:
  1. Nantahala Capital Management, (Major Shareholder)
  2. Roger M Klein (Major Shareholder)
Learn More about top insider investors at Evoke Pharma.

Who are the major institutional investors of Evoke Pharma?

Evoke Pharma's top institutional investors include:
  1. National Wealth Management Group LLC — 5.14%
Learn More about top institutional investors of Evoke Pharma stock.

Which institutional investors are buying Evoke Pharma stock?

In the last quarter, EVOK stock was acquired by institutional investors including:
  1. National Wealth Management Group LLC